Chromogranin A as Blood Marker in Cancer Patients

Clinical trial NCT03817866 · COMPLETED

Trial details

NCT number: NCT03817866
Sponsor: Brahms AG
Status: COMPLETED
Study type: OBSERVATIONAL

Gastric Neoplasms Pancreatic Neoplasms Small Intestinal Neoplasms Colorectal Neoplasms

Start date: 2019-01-29
Primary completion: 2021-12-14
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.